JMIA vs WOOF
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Jumia Technologies exhibits severe financial distress, highlighted by a critical Piotroski F-Score of 1/9, indicating a near-total failure of fundamental health metrics. While the company maintains strong top-line revenue growth of 34.4%, this is offset by a devastating ROE of -109.87% and a Price-to-Book ratio of 32.26, which suggests extreme overvaluation relative to its equity. The lack of a Graham Number or Intrinsic Value reflects the absence of positive earnings, making the stock a highly speculative play. Despite bullish analyst targets, the deterministic data points to a high-risk profile with significant capital erosion over the long term.
WOOF presents a high-risk profile characterized by a stable but mediocre Piotroski F-Score of 4/9 and a current price ($2.99) that significantly exceeds both its Graham Number ($1.67) and Intrinsic Value ($0.21). The company is struggling with negative revenue growth (-2.40%) and razor-thin profit margins (0.15%), indicating a lack of pricing power or rising operational costs. Financial health is precarious, evidenced by a high Debt/Equity ratio of 2.48 and a critically low Quick Ratio of 0.27. While analysts maintain a 'Hold' rating with a target of $3.52, the combination of bearish insider sentiment and a 0/100 technical trend suggests strong downward pressure.
Compare Another Pair
Related Comparisons
JMIA vs WOOF: Head-to-Head Comparison
This page compares Jumia Technologies AG (JMIA) and Petco Health and Wellness Company, Inc. (WOOF) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.